Scientists find biomarker for bowel cancer drug

Irish scientists have discovered a biomarker that can predict patients who will benefit the most from a key drug used to treat bowel cancer.

Bowel cancer is the fourth most common cancer in Ireland, with 2,500 diagnosed with the disease each year.

Scientists here and in the Netherlands, part of the AngioPredict research consortium, discovered the bio-marker.